Unmatched industry expertise
Our team of experienced investors and medical professionals brings deep knowledge to every investment decision, with a track record of identifying and backing successful medical technology companies.
Private equity · Medical technology
Transforming medical technologies, one careful investment at a time.
We back the early-stage companies building the medicine that comes next — sourced through a national network of physicians who see what works long before the market does.
Investing in the future of medicine
Access is the whole advantage.
The Oxford Fund is committed to investing in the most promising early-stage companies developing transformative medical technologies.
Our national network of physicians gives us access to deal flow that does not reach the open market — clinicians who encounter a technology in practice, and can tell us whether it actually changes an outcome. That access is what lets us identify the opportunities worth pursuing, and pass on the ones that only look good on paper.
A flexible investment approach
Every company is different. We tailor our approach to the business in front of us — whether that means seed capital or the support required to scale an operation that is already moving.
Partnership, not just capital
We work closely with our portfolio companies and keep a network of industry experts and advisors on hand, because strong partnerships are what carry a company from promise to proof.
Where we look
Transformative medical technologies.
We invest across the technologies that change how care is delivered and measured — from the instrument in a clinician's hand to the data that proves it worked.
- Medical devices
- Biotech & life sciences
- Telemedicine
- Medical data science
Latest insight
The Evolving Landscape of Private Equity in 2023: Navigating Opportunities and Challenges
Economic shifts, tech-driven transformation, ESG imperatives, and a changing regulatory picture — the forces reshaping private equity and how firms are responding.
Read the piece
Ready to talk about the future of medicine?
Whether you are building a medical technology company or looking to invest in one, we would like to hear from you.